Does grapefruit help with weight loss?

Not in any way the trials can separate from eating something filling before a meal. A 2017 meta-analysis pooled 3 randomized trials in 250 overweight or obese adults and found no significant difference in weight between grapefruit and control: a mean difference of -0.99 lb (-0.45 kg), with an interval from -1.06 to 0.16. The trials ran 6 to 12 weeks and were rated moderate quality.

Myth. No trial shows grapefruit itself takes weight off. When obese adults on a reduced-calorie diet drank the same amount of water before meals instead of eating grapefruit, their weight loss did not differ.

What the trials found

The trial behind the claim

In a 12-week randomized trial of 91 obese adults, the group eating fresh grapefruit before each meal lost 3.5 lb (1.6 kg), the juice group 3.3 lb (1.5 kg), the capsule group 2.4 lb (1.1 kg) and the placebo group 0.66 lb (0.3 kg). Only fresh fruit against placebo reached significance. The placebo group took a capsule instead of fruit, so eating extra fruit before meals, rather than anything special in grapefruit, may explain the gap. In a secondary analysis of people with metabolic syndrome, all three grapefruit forms beat placebo for weight, and fresh grapefruit lowered the 2-hour insulin level after a glucose drink. The abstract does not say how many people were in that subgroup.

The trials with a fairer control

A 12-week trial put 85 obese adults on a reduced-calorie diet with a 127 g preload before meals: grapefruit, grapefruit juice or water. During the preload phase they lost a further 5.8, 13 and 15 lb (5.9 and 6.7 kg), and adjusted for starting weight the groups did not differ. About a fifth dropped out. HDL cholesterol rose 6.2 percent with grapefruit and 8.2 percent with juice and fell 3.7 percent with water, a secondary outcome. In a 6-week trial of 74 overweight adults, eating grapefruit daily did not lower weight, blood pressure or lipids against the control diet.

One number that did move

The 2017 meta-analysis found systolic blood pressure 2.43 mmHg lower with grapefruit, an interval from -4.77 to -0.09. That was a secondary outcome, and the upper end sits close to zero.

Grapefruit extract pills

A 28-day trial gave 20 overweight adults a supplement with 100 mg of naringin, a grapefruit flavonoid, mixed with satiereal and vitamin D3. It had no detectable effect on body mass or waist. With three ingredients in one capsule, naringin alone was never tested.

Unsettled. The meta-analysis authors explain why the answer stays soft: too few trials, short durations and no established minimum effective dose limit any conclusion about grapefruit and body weight.

Who should be careful

Not for everyone. Grapefruit before every meal is not neutral if you take medicines. The US FDA explains that grapefruit juice can block the gut enzyme CYP3A4, so more of some drugs enters the blood and stays in the body longer. If you take any regular medicine, check with a pharmacist before making grapefruit a daily habit.

Blood pressure medicines are the clearest case, and the interaction runs both ways. A meta-analysis of pharmacokinetic studies names dihydropyridine calcium channel blockers as the drugs most prone to it, with drug levels raised in healthy volunteers. A 2025 meta-analysis of 51 studies found grapefruit juice cut blood levels of aliskiren and celiprolol by about 80 to 90 percent. Those studies were small and mostly did not measure blood pressure itself.

What expert bodies say

We found no position from NIH, EFSA, WHO or NICE on grapefruit and weight, and no authorized EU health claim for it. The agency statement on this page is the FDA warning on drug interactions above.

How we searched

What would change this answer

• A longer randomized trial comparing grapefruit with a preload of matched energy that is not grapefruit. We found none registered. A press report mentions a two-year trial, but we found no registration for it.
• A dose. The reviewers note nobody has established a minimum effective amount, so even a positive trial would not say how much to eat.

More on the fruit itself is on the grapefruit page.

Sources

1. ev-gfwl-01 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials, GRADE · n = 250
   One hundred and fifty four citations were identified and three RCTs with a total of 250 participants were included. The RCTs were of moderate quality. A meta-analysis for change in body weight failed to reveal a significant difference between grapefruits and controls, MD: -0.45 kg (95% CI: -1.06 to 0.16
   
   Who: overweight and obese adults in randomized clinical trials of grapefruit
   Effect: body weight MD -0.99 lb (95% CI -2.3 to 0.35; metric: -0.45 kg, -1.06 to 0.16), I2 53%
   Certainty: Only 3 trials of moderate quality, 6 to 12 weeks; authors note no established effective dose. Full text paywalled.
   Critical Reviews in Food Science and Nutrition, 2017, 57(3):602-612 · checked 2026-10-07 · we read the abstract
2. ev-gfwl-02 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials, GRADE · n = 250
   but analysis revealed a significant decrease in systolic blood pressure, MD: -2.43 mmHg (95% CI: -4.77 to -0.09
   
   Who: overweight and obese adults in randomized clinical trials of grapefruit
   Effect: systolic blood pressure MD -2.43 mmHg (95% CI -4.77 to -0.09), I2 0%
   Certainty: Secondary outcome, upper CI bound near zero.
   Critical Reviews in Food Science and Nutrition, 2017, 57(3):602-612 · checked 2026-10-07 · we read the abstract
3. ev-gfwl-03 · Meta-analysis or systematic review · systematic review and meta-analysis of randomized controlled trials · n = 250
   Paucity in the number of RCTs, short durations of interventions, and lack of an established minimum effective dose limit the conclusions that can be drawn about the effects of grapefruit on body weight and metabolic parameters.
   
   Who: overweight and obese adults in randomized clinical trials of grapefruit
   Effect: evidence gap: few RCTs, short duration, no minimum effective dose
   Certainty: Authors' own limitation statement.
   Critical Reviews in Food Science and Nutrition, 2017, 57(3):602-612 · checked 2026-10-07 · we read the abstract
4. ev-gfwl-04 · Randomized controlled trial(s) · randomized double-blind placebo-controlled trial, 4 arms, 12 weeks · n = 91
   After 12 weeks, the fresh grapefruit group had lost 1.6 kg, the grapefruit juice group had lost 1.5 kg, the grapefruit capsule group had lost 1.1 kg, and the placebo group had lost 0.3 kg. The fresh grapefruit group lost significantly more weight than the placebo group (P < .05).
   
   Who: obese patients, grapefruit or placebo three times a day before each meal
   Effect: fresh grapefruit -3.5 lb (-1.6 kg), juice -3.3 lb (-1.5 kg), capsule -2.4 lb (-1.1 kg), placebo -0.66 lb (-0.3 kg); fresh fruit vs placebo P < .05
   Certainty: Control was a placebo capsule rather than grapefruit, so the extra fruit before meals may explain the gap; only fresh fruit vs placebo reached significance.
   J Med Food, 2006 · checked 2026-10-07 · we read the abstract
5. ev-gfwl-05 · Randomized controlled trial(s) · secondary analysis of a randomized placebo-controlled trial · n = —
   A secondary analysis of those with the metabolic syndrome in the four treatment groups demonstrated a significantly greater weight loss in the grapefruit, grapefruit capsule, and grapefruit juice groups compared with placebo (P < .02). There was also a significant reduction in 2-hour post-glucose insulin level in the grapefruit group compared with placebo.
   
   Who: trial participants with the metabolic syndrome, secondary analysis
   Effect: greater weight loss with all grapefruit forms vs placebo (P < .02); lower 2-hour post-glucose insulin with fresh grapefruit
   Certainty: Subgroup analysis; subgroup size not in the abstract.
   J Med Food, 2006 · checked 2026-10-07 · we read the abstract
6. ev-gfwl-06 · Randomized controlled trial(s) · randomized controlled trial, 6 weeks · n = 74
   This study suggests that consumption of grapefruit daily for 6 weeks does not significantly decrease body weight, lipids, or blood pressure as compared with the control condition.
   
   Who: healthy overweight adults after a 3-week washout diet
   Effect: no between-group difference; within-group weight -1.3 lb (-0.61 kg) (P = .097), waist -0.96 in (-2.45 cm)
   Certainty: Short trial; waist and blood pressure fell only against baseline.
   Metabolism, 2012 · checked 2026-10-07 · we read the abstract
7. ev-gfwl-07 · Randomized controlled trial(s) · randomized controlled trial with 127 g preloads 20 minutes before meals, 12 weeks · n = 85
   The rate of weight loss increased significantly by 13.3% (p < .0001) during the caloric restriction + preload phase for an additional loss of 5.8 ± 3.9, 5.9 ± 3.6 and 6.7 ± 3.1 kg (GF, GFJ and water, respectively). Adjusted for baseline weight, total weight loss was not statistically different by group.
   
   Who: free-living obese adults on caloric restriction, randomized to grapefruit, grapefruit juice or water preloads
   Effect: additional loss 5.8, 13 and 15 lb (5.9 and 6.7 kg) (grapefruit, juice, water); not different by group after adjustment
   Certainty: 20% dropout; water control matched the preload volume, which points to the preload itself rather than grapefruit.
   Nutrition & Metabolism, 2011, 8:8 · checked 2026-10-07 · we read the fulltext
8. ev-gfwl-08 · Randomized controlled trial(s) · randomized controlled trial, 12 weeks · n = 85
   There was a mean increase in HDL-C from baseline by 6.2% in the GF group and 8.2% in the GFJ group - which differed significantly from the mean decrease of 3.7% in the water group (p = 0.003 and 0.009, respectively).
   
   Who: free-living obese adults on caloric restriction with preloads
   Effect: HDL-C +6.2% (grapefruit), +8.2% (juice), -3.7% (water); p = 0.003 and 0.009
   Certainty: Secondary outcome.
   Nutrition & Metabolism, 2011, 8:8 · checked 2026-10-07 · we read the fulltext
9. ev-gfwl-09 · Randomized controlled trial(s) · randomized double-blind placebo-controlled trial, 28 days · n = 20
   In conclusion, 28 days of a dietary supplement containing satiereal, naringin, and vitamin D3 did not have any detectable beneficial effects on body-weight management.
   
   Who: healthy overweight adults
   Effect: no difference vs placebo in body mass (p = 0.34), BMI or waist
   Certainty: Very small and short; multi-ingredient product, so naringin alone is not tested.
   J Diet Suppl, 2018 · checked 2026-10-07 · we read the abstract
10. ev-gfwl-10 · Position of an expert body · consumer guidance from a regulator · n = —
    Grapefruit juice can block the action of intestinal CYP3A4, so instead of being metabolized, more of the drug enters the blood and stays in the body longer.
    
    Who: people taking prescription or over-the-counter drugs
    Effect: higher drug levels for CYP3A4 substrates
    Certainty: Position without own analysis; page updated 07/01/2021. Relevant to anyone adding grapefruit three times a day.
    US Food and Drug Administration, Grapefruit Juice and Some Drugs Don't Mix, updated 2021 · checked 2026-10-07 · we read the section
11. ev-gfwl-11 · Observational data · meta-analysis of pharmacokinetic crossover studies · n = —
    Dihydropyridine calcium channel blockers belong to the category of drugs that are most prone to undergo such interaction.
    
    Who: healthy adults taking dihydropyridines with grapefruit juice vs water
    Effect: raised drug exposure for most dihydropyridines
    Certainty: Drug-level outcomes in healthy volunteers; randomization of included studies not stated.
    Curr Pharm Biotechnol, 2012 · checked 2026-10-07 · we read the abstract
12. ev-gfwl-12 · Observational data · systematic review and meta-analysis of mostly open-label crossover pharmacokinetic trials · n = 51 studies
    Grapefruit juice (GFJ), an inhibitor of organic-anion-transporting polypeptide (OATP) transporters and cytochrome P450 (CYP) 3A4, significantly decreased the AUC and Cmax of aliskiren and celiprolol by approximately 80-90 %.
    
    Who: humans in pharmacokinetic studies of fruit juice with antihypertensive drugs
    Effect: aliskiren and celiprolol AUC and Cmax down about 80-90% with grapefruit juice
    Certainty: Small, moderate-quality studies; blood pressure outcomes mostly not measured.
    Complement Ther Med, 2025 · checked 2026-10-07 · we read the abstract